Clinical Trial Update: Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether omega-3 fatty acids can reduce chemotherapy-induced neuropathy and inflammation in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN